Internal and external parasite threats have expanded beyond their traditional regions and seasons. Many tick species, for example, are now found in places that they didn't exist a decade ago, and they ...
Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...
The NMC also asked doctors to avoid prescribing branded generic drugs. Boehringer Ingelheim on Thursday announced the launch of NexGard (afoxolaner) S and M in India. According to a press statement, ...
The maker of HEARTGARD® Plus (ivermectin/pyrantel), the #1 vet-recommended and #1 dog-preferred real beef chew,1, 2 introduces the latest innovation in its portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results